Responses
Clinical/translational cancer immunotherapy
Original research
HPV-16 E6/E7 DNA tattoo vaccination using genetically optimized vaccines elicit clinical and immunological responses in patients with usual vulvar intraepithelial neoplasia (uVIN): a phase I/II clinical trial
Compose a Response to This Article
Other responses
No responses have been published for this article.
